Codexis, Inc. (CDXS) Financials
CDXS Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2024-03-31 | 149.6 million | 70.3 million |
2023-12-31 | 136.6 million | 49.9 million |
2023-09-30 | 154.5 million | 62.9 million |
2023-06-30 | 206.8 million | 82.6 million |
CDXS Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2024-03-31 | -8.9 million | ? |
2023-12-31 | -10.7 million | 2.2 million |
2023-09-30 | -17.0 million | 2.3 million |
2023-06-30 | -17.7 million | 2.7 million |
CDXS Net Income
No data available :(
CDXS Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2024-03-31 | 86.0 million | - | - |
2023-12-31 | 65.6 million | - | 16.0 million |
2023-09-30 | 74.6 million | - | 20.0 million |
2023-06-30 | 92.1 million | - | 41.0 million |
CDXS Shares Outstanding
CDXS Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2024-03-31 | 1.1 million | 10.2 million | - | - |
2023-12-31 | 380000 | 11.2 million | 10.7 million | 300000 |
2023-09-30 | 678000 | 13.7 million | 12.3 million | - |
2023-06-30 | 1.6 million | 17.3 million | 13.4 million | - |
CDXS Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2024-03-31 | 17.1 million | 6.1 million |
2023-12-31 | 26.6 million | 4.1 million |
2023-09-30 | 9.3 million | 2.2 million |
2023-06-30 | 21.3 million | 3.2 million |
CDXS
Price: $3.56
52 week price:
Earnings Per Share: -1.12 USD
P/E Ratio: -2.37
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Volume: 517700
Ebitda: -9.8 millionMarket Capitalization: 276.6 million